Amphastar Pharmaceuticals (AMPH) Other Non-Current Assets (2013 - 2026)

Amphastar Pharmaceuticals' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $33.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 45.62% year-over-year to $33.5 million; the TTM figure through Mar 2026 stood at $33.5 million (up 45.62% YoY), while the FY2025 annual figure was $31.1 million, up 19.79% from the prior year.
• Other Non-Current Assets was $33.5 million for Q1 2026 at Amphastar Pharmaceuticals, up from $31.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $33.5 million in Q1 2026 to a low of $16.3 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $24.1 million across 5 years, with a median of $23.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 126.03% in 2022, then dropped 6.47% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $20.9 million in 2022, then climbed by 24.23% to $25.9 million in 2023, then gained by 0.32% to $26.0 million in 2024, then gained by 19.79% to $31.1 million in 2025, then increased by 7.53% to $33.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $33.5 million (Q1 2026), $31.1 million (Q4 2025), and $29.9 million (Q3 2025), per Business Quant data.